Open Access<p>Cancer Care Management During the COVID-19 Pandemic</p>
Author(s) -
Ameneh Jafari,
Mostafa RezaeiTavirani,
Samira Karami,
Mohsen Yazdani,
Hakimeh Zali,
Zahra Jafari
Publication year - 2020
Publication title -
risk management and healthcare policy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.828
H-Index - 22
ISSN - 1179-1594
DOI - 10.2147/rmhp.s261357
Subject(s) - pandemic , covid-19 , medicine , coronavirus , intensive care medicine , epidemiology , cancer , disease , virology , infectious disease (medical specialty) , outbreak
New cases of the novel coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are increasing around the world. Currently, health care services are mainly focused on responding to and controlling the unique challenges of the coronavirus disease 2019 (COVID-19) pandemic. These changes, along with the higher susceptibility of patients with cancer to infections, have profound effects on other critical aspects of care and pose a serious challenge for the treatment of such patients. During the COVID-19 pandemic, it is important to provide strategies for managing the treatment of patients with cancer to limit COVID-19-associated risks at this difficult time. The present study set out to summarize the latest research on epidemiology, pathogenesis, and clinical features of COVID-19. We also address some of the current challenges associated with the management of patients with cancer during the COVID-19 pandemic and provide practical guidance to clinically deal with these challenges.